Treatment response and tolerability with once-monthly paliperidone palmitate initiated shortly after hospital admission in patients with schizophrenia-Reference-Cited by-同舟云学术

Treatment response and tolerability with once-monthly paliperidone palmitate initiated shortly after hospital admission in patients with schizophrenia

Published:2017-06-08 Issue:sup3 Volume:19 Page:S147-S157
ISSN:1562-2975
Container-title:The World Journal of Biological Psychiatry
language:en
Short-container-title:The World Journal of Biological Psychiatry

Author:

Hargarter Ludger¹,Lahaye Marjolein²,Cherubin Pierre³,Lambert Martin⁴,Swarz Marnina⁵,Joldygulov Gali⁶,Vischia Flavio⁷,Chomskaya Veronica⁸,Bozikas Vasilis P.⁹,Tsapakis Eva-Maria¹⁰,Schreiner Andreas¹

Affiliation:

1. Medical & Scientific Affairs, Janssen Cilag EMEA, Neuss, Germany;

2. Biostatistics & Programming, Janssen Cilag Benelux, Tilburg, The Netherlands;

3. Medical Affairs, Janssen Cilag EMEA, Issy-les-Moulineaux, France;

4. University Medical Center, Eppendorf, Hamburg, Germany;

5. Abarbanel Mental Health Center, Bat Yam, Israel;

6. Republican Scientific Center of Psychiatry, Almaty, Kazakhstan;

7. Dipartimento di Salute Mentale, Ospedale Amedeo di Savoia, Torino, Italy;

8. State Institution of Healthcare City Psychoneurological Dispensary #3, St Petersburg, Russia;

9. 1st Psychiatric Clinic of the Aristotle University of Thessaloniki, General Hospital “Papageorgiou”, Thessaloniki, Greece;

10. Aghios Charalambos’ Mental Health Clinic, Heraklion, Crete, Greece

Funder

Janssen Pharmaceutica NV

Publisher

Informa UK Limited

Subject

Biological Psychiatry,Psychiatry and Mental health

Link

https://www.tandfonline.com/doi/pdf/10.1080/15622975.2017.1315176

Reference41 articles.

1. Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, double-blind clinical trial

2. American Psychiatric Association. 2010. Practice guideline for the treatment of patients with schizophrenia. [Internet]. [cited 2017 Apr]. Available from: http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/schizophrenia.pdf

3. The cost of relapse and the predictors of relapse in the treatment of schizophrenia

4. Paliperidone palmitate long-acting injection - prospective year-long follow-up of use in clinical practice

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STUDY ON TOLERABILITY AND EFFICACY OF PALIPERIDONE PALMITATE, OLANZAPINE PAMOATE AND RISPERIDONE LONG ACTING INJECTION IN A ROMANIAN SAMPLE OF PATIENTS WITH SCHIZOPHRENIA;FARMACIA;2020-04-15